| Literature DB >> 30087794 |
Alireza Tavakkoli1, Vahid Mahdian2, Bibi Marjan Razavi3, Hossein Hosseinzadeh4.
Abstract
OBJECTIVES: Nigella sativa (black seed or black cumin), which belongs to the Ranunculacea family, is an annual herb with many pharmacological properties. Among its many active constituents, thymoquinone (TQ) is the most abundant constituent of the volatile oil of Nigella sativa (N. sativa) seeds, and it is the constituent to which most properties of this herb are attributed.Entities:
Keywords: Nigella sativa; black seed; clinical trials; diseases; safety; thymoquinone
Year: 2017 PMID: 30087794 PMCID: PMC5633670 DOI: 10.3831/KPI.2017.20.021
Source DB: PubMed Journal: J Pharmacopuncture ISSN: 2093-6966
Figure 1Schematic description for the effects of Nigella sativa in different parts of the human body.
Effects of Nigella sativa supplementation on patients with diabetes
| Study design | Population | Part of the herb, dose, and duration of treatment | Result | References |
|---|---|---|---|---|
| Randomized, double-blind, placebo-controlled trial | 72 Type 2 DM patients (men and women aged 30 – 60 years old) | NS oil (3 g/day)12 weeks | ↓ BMI, insulin level and insulin resistance as well as HDL-C as compared with baseline, ↓ FBS, TG, LDL-C and HbA1c as compared to the placebo group | [ |
|
| ||||
| - | 41 Type 2 DM patients (men and women aged 30 – 60 years old) | NS oil (equivalent to oil obtained from 0.7 g of seeds)40 days | ↓ FBS, ↑ insulin, but reversed after 40 days of placebo administration | [ |
|
| ||||
| Prospective study | 60 patients with insulin resistance (men and women) | NS oil (5 mL/day) + atorvastatin (10 mg/day) and metformin (1 g/day)6 weeks | ↓ TC, LDL-C and FBS | [ |
|
| ||||
| Randomized, double blind, placebo-controlled clinical trial | 43 Type 2 DM patients (men and women) | NS oil extract (1 g/day)8 weeks | ↓ TG, LDL-C, TC, and LDL-C to HDL-C ratios as compared to the placebo | [ |
|
| ||||
| - | 41 type 2 DM patients (men and women) | NS tea (5 g/day) + usual oral anti-diabetic drugs, diet, and exercises6 months | ↓ FBG, PPBG and HbA1c | [ |
|
| ||||
| - | 94 type 2 DM patients (men and women) | NS seeds 2 g/day or 3 g/day12 weeks | ↓ FBG, 2hPG, and HbA1c, ↓ Insulin resistance, ↑ β-cell function; no significant change in body weight | [ |
| NS seeds 1 g/day,12 weeks | Insignificant changes | [ | ||
|
| ||||
| - | 41 type 2 DM patients (men and women aged 30 – 60 years old) | NS seed powder, 40 days | ↓ FBG, TC, LDL-C and TG, ↑ HDL-C and insulin; all mentioned values except HDL significantly reversed again after 40 days of placebo intake | [ |
DM, Diabetes mellitus; NS, Nigella sativa; BMI, Body mass index; HDL-C, High density lipoprotein-cholesterol; TG, Triglyceride; LDL-C, Low density lipoprotein-cholesterol; HbA1c, Haemoglobin A1c; FBS, Fasting blood sugar; TC, Total cholesterol; FBG, Fasting blood glucose; PPBG, Postprandial blood glucose; 2hPG, 2 hours postprandial glucose.
Clinical effects of Nigella sativa supplementation on the nervous system
| Study design | Population | Part of the herb, dose, and duration of treatment | Result | References |
|---|---|---|---|---|
| Double-blinded crossover clinical trial | 23 epileptic children | Water extract of black seed (40 mg/kg/8 h), 10 weeks | Significant reduction of mean frequency of seizures | [ |
| Pilot, double-blinded crossover clinical trial | 22 epileptic children | Thymoquinone (1 mg/kg), 10 weeks | Significant reduction of frequency of seizures | [ |
| Prospective, randomized, single-blinded, controlled, crossover pilot study | 30 intractable epileptic patients | 40 – 80 mg/kg/day of black seed oil, 10 weeks | No beneficial effects in the frequency and severity of seizures | [ |
| Placebo-controlled clinical trial | 40 healthy elderly volunteers | 500 mg NS seed capsule twice a day, 9 weeks | Improvement of cognition, memory, and attention | [ |
| Placebo-controlled clinical trial | 48 healthy adolescent males | 500 mg NS capsule once daily, 4 weeks | Enhancements of mood, anxiety, and cognition | [ |
| - | 35 male opiate addicts | 500 mg NS daily, 12 weeks | Significant reduction of withdrawal effects | [ |
| Randomized, triple-blind, active, and placebo-controlled clinical trial | 52 women with cyclic mastalgia | Topical 600 mg NS oil twice a day, 2 months | Significant improvement of the pain scores | [ |
NS, Nigella sativa.
Effects of Nigella sativa supplementation on patients with some diseases of the respiratory system
| Disease | Study design | Population | Part of the herb, dose, and duration of treatment | Result | References |
|---|---|---|---|---|---|
| Lower respiratory tract illnesses | - | 15 asthmatic patients | NS boiled extract(50 and 100 mg/kg) | NS was less effective than theophylline and salbutamol, on pulmonary function tests | [ |
| Controlled clinical trial | 29 asthmatic adults | 15 mL/kg/day of 0.1% NS boiled extract, 3 months | Prophylactic effects of NS on asthmatic patients | [ | |
| Prospective, randomized, open study | 84 patients of wheeze associated LRTI | NS oil (0.1 mg/kg), 14 days | More beneficial effects in reducing the pulmonary index and improving the peak expiratory flow rate | [ | |
| Randomized, double-blind, placebo-controlled trial | 40 chemical war victims | 0.375 mL/kg/day of 50 g NS boiled water extract, 2 months | Prophylactic effect of NS on chemical war victims | [ | |
|
| |||||
| Allergic rhinitis | Single-blind comparative clinical trial | 47 untreated adult patients with seasonal allergic rhinitis | NS seeds (250 mg/day), 2 weeks | Decreasing daytime, ophthalmic, and nighttime symptoms | [ |
| Double-blind clinical trial | 68 patients with allergic rhinitis | Nasal drops of NS oil (each drop: 15 mL oil), 6 weeks | Notable symptomatic improvement of patients | [ | |
|
| |||||
| Tonsillopharyngitis | Comparative, parallel, randomized, double-blind, placebo-controlled study | 186 acute tonsillopharyngitis patients | NSPN capsule (360 mg NS and 50 mg | Treatment of the symptoms of the disease | [ |
NS, Nigella sativa.